Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIK3CD | O00329 | 12/20 | 0.45 |
| ▸ | PIK3R1 | P27986 | 1/20 | 0.41 |
| ▸ | PIK3CG | P48736 | 5/20 | 0.38 |
| ▸ | PIK3R2 | O00459 | 2/20 | 0.38 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.38 |
| ▸ | PIK3CA | P42336 | 2/20 | 0.38 |
| ▸ | PIK3CB | P42338 | 1/20 | 0.38 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16596152 | 0.92 | PIK3CD (0.47) | PIK3CDPIK3R1PIK3CGPIK3R2PIK3CA | |
| SCHEMBL16596143 | 0.85 | PIK3CD (0.48) | PIK3CDPIK3R1PIK3CGPIK3R2PIK3CA | |
| SCHEMBL16596822 | 0.85 | CYP1A2 (0.41) | PIK3CDPIK3R1PIK3CGMAPK14PIK3CA | |
| SCHEMBL18885591 | 0.83 | MAPK14 (0.46) | PIK3CDPIK3CGPIK3R2MAPK14NOTUM | |
| SCHEMBL22237967 | 0.83 | ALDH1A1 (0.50) | PIK3CDPIK3CGPIK3R2NOTUMKDM4E | |
| SCHEMBL16591277 | 0.82 | PIK3CD (0.41) | PIK3CDPIK3R1PIK3CGPIK3CAPIK3CB | |
| SCHEMBL14726573 | 0.80 | PIK3CD (0.47) | PIK3CDPIK3R1PIK3CGPIK3R2PIK3CA | |
| SCHEMBL16596962 | 0.80 | PIK3CD (0.55) | PIK3CDPIK3R1PIK3CGPIK3R2PIK3CA | |
| SCHEMBL16591302 | 0.78 | PIK3CD (0.39) | PIK3CDPIK3R1PIK3CGPIK3R2PIK3CA | |
| SCHEMBL16596148 | 0.77 | NOTUM (0.48) | PIK3CDNOTUMKDM4ENPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9657007-B2 | Substituted aminopyrimidine compounds and methods of use | CALITOR SCIENCES, LLC (US) | 2017-05-23 | — | — | US | disclosed |
| US-20150087658-A1 | SUBSTITUTED AMINOPYRIMIDINE COMPOUNDS AND METHODS OF USE | CALITOR SCIENCES, LLC (US) | 2015-03-26 | — | — | US | disclosed |
| WO-2015042078-A2 | SUBSTITUTED AMINOPYRIMIDINE COMPOUNDS AND METHODS OF USE | CALITOR SCIENCES, LLC (US) | 2015-03-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150087658-A1 | SUBSTITUTED AMINOPYRIMIDINE COMPOUNDS AND METHODS OF USE | PIK3CA, PIK3CD, MYD88 | PIK3CD 2/4885PIK3R1 9/4885PIK3CG 6/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.